18-Methyltestosterone

From WikiMD's WELLNESSPEDIA

Chemical structure of 18-Methyltestosterone

18-Methyltestosterone is a synthetic androgen and anabolic steroid (AAS) that is used in the treatment of male hypogonadism, delayed puberty in boys, and in low doses as a component of hormone therapy for transgender men. It is also used in the treatment of breast cancer in women, though this use is less common.

Chemical Properties[edit]

18-Methyltestosterone is a derivative of testosterone, the primary male sex hormone and an anabolic steroid. It is characterized by the addition of a methyl group at the 18th carbon position of the steroid structure, which distinguishes it from testosterone. This modification enhances its oral bioavailability and makes it more resistant to metabolic degradation.

Mechanism of Action[edit]

As an androgen, 18-Methyltestosterone binds to the androgen receptor in target tissues. This binding activates the receptor, leading to changes in gene expression that result in the development and maintenance of male secondary sexual characteristics and anabolic effects such as increased muscle mass and strength.

Medical Uses[edit]

18-Methyltestosterone is primarily used in the treatment of conditions associated with low testosterone levels. These include:

  • Hypogonadism in males, where the body does not produce enough testosterone.
  • Delayed puberty in boys, to stimulate the development of secondary sexual characteristics.
  • As part of hormone therapy for transgender men, to induce masculinization.
  • Occasionally, in the treatment of breast cancer in women, due to its anti-estrogenic effects.

Side Effects[edit]

The use of 18-Methyltestosterone can lead to a range of side effects, particularly when used in high doses or for extended periods. Common side effects include:

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.